| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
144,920,000 |
| Market
Cap: |
36.45(B) |
| Last
Volume: |
488,923 |
Avg
Vol: |
789,838 |
| 52
Week Range: |
$204.54 - $293.73 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 237 |
| Guru Rank Value : 6.7 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile ResMed is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Co. operates in two segments: Sleep and Respiratory Care, which relates primarily to the sale of its products that are therapy-based equipment; and Software as a Service, which relates to the provision of software access with ongoing support and maintenance services as well as services such as training and consulting.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
34,671 |
74,217 |
149,063 |
366,446 |
| Total Sell Value |
$9,236,828 |
$19,705,518 |
$37,217,676 |
$85,289,250 |
| Total People Sold |
5 |
6 |
7 |
9 |
| Total Sell Transactions |
9 |
20 |
45 |
78 |
| End Date |
2025-09-04 |
2025-06-03 |
2024-12-03 |
2023-12-04 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Farrell Peter C |
Director |
• • – |
2025-12-03 |
4 |
AS |
$251.47 |
$502,940 |
D/D |
(2,000) |
68,773 |
|
- |
|
| Rider Michael J |
Global General Counsel |
• • – |
2025-12-01 |
4 |
AS |
$244.16 |
$12,208 |
D/D |
(50) |
9,791 |
|
- |
|
| Sandercock Brett |
Chief Financial Officer |
• • – |
2025-12-01 |
4 |
AS |
$244.16 |
$244,160 |
D/D |
(1,000) |
87,495 |
|
- |
|
| De Witte Jan |
Director |
• • – |
2025-11-25 |
4 |
AS |
$255.00 |
$524,025 |
D/D |
(2,055) |
4,261 |
|
0% |
|
| Mowad-Nassar Nicole |
Director |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
536 |
777 |
|
- |
|
| Farrell Peter C |
Director |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
536 |
70,773 |
|
- |
|
| Tan Desney |
Director |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,073 |
6,002 |
|
- |
|
| Taylor Ronald R |
Director |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,073 |
24,771 |
|
- |
|
| De Witte Jan |
Director |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,073 |
6,316 |
|
- |
|
| Delorefice Christopher |
Director |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,073 |
2,423 |
|
- |
|
| Gill Harjit |
Director |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,073 |
10,940 |
|
- |
|
| Leong Justin |
Chief Product Officer |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,848 |
29,028 |
|
- |
|
| Burt Carol |
Director |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,073 |
2,156 |
|
- |
|
| Farrell Michael J. |
Chairman and CEO |
• • – |
2025-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,297) |
466,223 |
|
- |
|
| Farrell Michael J. |
Chairman and CEO |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
13,551 |
473,520 |
|
- |
|
| Hernandez John |
Director |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,073 |
5,118 |
|
- |
|
| Drexler Karen |
Director |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,073 |
10,602 |
|
- |
|
| Sandercock Brett |
Chief Financial Officer |
• • – |
2025-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,710 |
88,495 |
|
- |
|
| Farrell Peter C |
Director |
• • – |
2025-11-14 |
4 |
D |
$244.46 |
$1,787,980 |
D/D |
(7,314) |
70,238 |
|
- |
|
| Farrell Peter C |
Director |
• • – |
2025-11-14 |
4 |
OE |
$101.64 |
$1,162,965 |
D/D |
11,442 |
77,552 |
|
- |
|
| Farrell Peter C |
Director |
• • – |
2025-11-12 |
4 |
AS |
$252.05 |
$504,100 |
D/D |
(2,000) |
66,110 |
|
1% |
|
| Gill Harjit |
Director |
• • – |
2025-11-11 |
4 |
D |
$250.10 |
$9,556 |
D/D |
(38) |
9,867 |
|
- |
|
| De Witte Jan |
Director |
• • – |
2025-11-11 |
4 |
D |
$250.10 |
$19,120 |
D/D |
(76) |
5,242 |
|
- |
|
| De Witte Jan |
Director |
• • – |
2025-11-11 |
4 |
AS |
$250.25 |
$121,872 |
D/D |
(487) |
5,319 |
|
1% |
|
| Rider Michael J |
Global General Counsel |
• • – |
2025-11-11 |
4 |
D |
$250.10 |
$381,409 |
D/D |
(1,525) |
9,841 |
|
- |
|
1166 Records found
|
|
Page 1 of 47 |
|
|
0.07 (0.03%) 
